Nano into Micro Formulations of Tobramycin for the Treatment of Pseudomonas aeruginosa Infections in Cystic Fibrosis-Reference-Cited by-同舟云学术

Nano into Micro Formulations of Tobramycin for the Treatment of Pseudomonas aeruginosa Infections in Cystic Fibrosis

Published:2017-11-16 Issue:12 Volume:18 Page:3924-3935
ISSN:1525-7797
Container-title:Biomacromolecules
language:en
Short-container-title:Biomacromolecules

Author:

Porsio Barbara¹,Cusimano Maria Grazia¹,Schillaci Domenico¹,Craparo Emanuela Fabiola¹,Giammona Gaetano¹²,Cavallaro Gennara¹^ORCID

Affiliation:

1. Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Università di Palermo, Via Archirafi 32, 90123 Palermo, Italy

2. Mediterranean Center for Human Health Advanced Biotechnologies (CHAB), ATeN Center, University of Palermo, Viale delle Scienze, Ed. 18, Palermo, Italy

Publisher

American Chemical Society (ACS)

Subject

Materials Chemistry,Polymers and Plastics,Biomaterials,Bioengineering

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.biomac.7b00945

Reference33 articles.

1. Cystic Fibrosis

2. Extracellular barriers in respiratory gene therapy

3. Regulation of Airway Surface Liquid Volume and Mucus Transport by Active Ion Transport

4. Nanocomplexes for gene therapy of respiratory diseases: Targeting and overcoming the mucus barrier

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TAT decorated siRNA polyplexes for inhalation delivery in anti-asthma therapy;European Journal of Pharmaceutical Sciences;2023-11

2. Codelivery of synergistic antimicrobials with polyelectrolyte nanocomplexes to treat bacterial biofilms and lung infections;Science Advances;2023-01-20

3. Modulation of engineered nanomaterial interactions with organ barriers for enhanced drug transport;Chemical Society Reviews;2023

4. Nano-in-Microparticles for Pulmonary Drug Delivery;Pulmonary Drug Delivery Systems: Material and Technological Advances;2023

5. Inhalable responsive polysaccharide-based antibiotic delivery nanoparticles to overcome mucus barrier for lung infection treatment;Nano Today;2022-06